In this session, our panelists discuss how legislative reform may reorient how the federal government regulates cannabis. Focusing on the Cannabis Administration and Opportunity Act (CAOA), the Marijuana Opportunity Reinvestment and Expungement Act (MORE), and the States Reform Act (SRA), our panelists will discuss how these proposals would change how the the relevant agencies (such as USDA, FDA, TTB, and PTO) regulate the cannabis sector. Are there unanswered questions or unintended consequences? What would the regulatory landscape look like in the post-legalization United States? Are any of these proposals a panacea for what ails the industry in various verticals?
This program is eligible for 1.25 hours of General CLE credit in 60-minute states, and 1.4 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|Federal Agencies presentation 22-6-8 (12.1 MB)||Available after Purchase|
|Rob Tobiassen - CLI Federal Agencies Outline-27-05-2022 171936982 (32 KB)||Available after Purchase|
|Rob Tobiassen -TTB FREQUENTLY ASKED QUESTIONS Cannabis-27-05-2022 171936983 (31.4 KB)||Available after Purchase|
Cynthia L. Meyer is a partner at Kleinfeld, Kaplan & Becker, LLP, whose practice focuses on FDA law and advertising law. She regularly provides counsel to and advocates on behalf of clients in FDA-regulated industries, particularly in the dietary supplement, food, cosmetic, and pharmaceutical industries. She advises on legal and regulatory matters involving various federal and state agencies, including the US Food and Drug Administration, Federal Trade Commission (FTC), US Department of Agriculture (USDA), and Consumer Product Safety Commission (CPSC), and has represented clients in advertising disputes in front of the National Advertising Division (NAD).
Cynthia frequently speaks and writes on a host of FDA and advertising issues, including dietary supplement labeling and structure-function claims requirements, advertising claims substantiation, and the regulation of hemp/CBD. She has authored or co-authored chapters and articles in multiple publications, such as A Practical Guide to FDA’s Food and Drug Law Regulation (multiple editions), Bringing Your Pharmaceutical Drug to Market (2015), and Law360. She currently serves on the Food and Drug Law Journal Editorial Advisory Board and has previously served on the Food and Drug Law Institute’s Advertising & Promotion for Medical Products committee and its Food Advertising, Labeling, and Litigation committee. Cynthia has also been recognized in the 2022 edition of The Best Lawyers in America® for FDA Law.
Cynthia received her J.D. from Georgetown University Law Center and her B.S. in biology from Duke University.
Executive leader of trade association representing importers of distilled spirits, wine, beer, and non-alcoholic beverages since 1935, on key regulatory and public policies at the Federal, State, and International levels impacting trade and supply chain distribution in goods and accompanying services.
Rob Kimmer is Head of Trademarks, focusing on the prosecution and litigation of worldwide trademark, copyright, brand, advertising, entertainment, and trade secret matters. He also focuses on the intersection of venture capital, early-stage/emerging companies, and intellectual property along with celebrity branding/endorsement matters and the Firm’s internationally-recognized cannabis practice.
Mr. Kimmer assists clients with worldwide naming/branding projects, trademark clearance reports, securing portfolios of trademark and domain registrations as well as enforcement of these valuable intellectual property assets. His specialty is developing business-centric and cost-effective IP strategies that meet each client’s specific needs. He has experience counseling clients with regard to sensitive copyright matters, such as certification testing materials and proprietary computer program code along with difficult-to-protect certification, sound, trade dress, and color registrations.
Having filed and won the first ever .XXX Domain Rapid Evaluation Service (RES) proceeding in the world, Mr. Kimmer is well-versed in domain name matters. He has successfully handled a variety of international disputes and Uniform Domain-Name Dispute Resolution Policy (UDRP) proceedings. Mr. Kimmer’s world-renowned expertise in the cannabis, CBD, and psychedelic branding space is recognized by INCBA (The International Cannabis Bar Association) and peer industry groups. He is currently counsel on a major CBD/cannabis trademark case before the U.S. Court of Appeals for the Federal Circuit – In Re Joy Tea – 22-1041.
Mr. Kimmer has counseled Fortune 100 and Fortune 500 companies, technology start-ups, venture capital firms, Oscar®-winning actors (serving as General Counsel of management teams), Grammy®-winning singers, accelerators, cannabis companies, and non-profit organizations in regard to trademarks, branding, naming projects, prosecution, trade dress, trade secrets, copyright, and IP enforcement. He has developed unique industry specialties in the CPG, toy/game, cosmetic, banking, beverage, alcohol, beer, restaurant, food, cannabis, and celebrity branding spaces. Mr. Kimmer understands the true value of branding/trademarks and can ensure that these valuable corporate assets are fully cared-for and protected.
Prior to joining Mei & Mark, LLP, Mr. Kimmer was an attorney at the Washington, D.C. offices of Michael Best and Rader Fishman & Grauer, as well as serving as practice group chair of an IP boutique. He has also worked as in-house counsel for Maple Life Financial®/MLF® Financial Group, a financial and insurance company that is a joint venture with Morgan Stanley®, Reservoir Capital®, and Cantor Fitzgerald®.
In Re Joy Tea – 22-1041 (CAFC)
In Re Joy Tea (TTAB)
Ford Motor Company vs. Mustangs Unlimited Inc. (6th Cir)
Patron Spirits International AG v. Mountain Melodies, LLC (TTAB)
Successful settlement against Marvel®
Successful settlement against Apple®
Successful Settlement against PSI®
TV game show veteran – having appeared on Win Ben Stein’s Money® and NBC®’s Million Second Quiz® (hosted by Ryan Seacrest), and The Game Show Network®
Mai Dinh is the Assistant General Counsel for Marketing, Regulatory, and Food Safety Programs Division where she manages a staff of attorneys providing legal advice to the Agricultural Marketing Service, including the recent regulations on the Domestic Hemp Production Program and the National Bioengineered Food Disclosure Standard. Prior to USDA, she was the Assistant Chief Counsel for Regulations at the Transportation Security Administration (TSA) where she guided significant rulemaking actions and program developments on passenger information screening and general aviation security. Prior to TSA, she supervised teams of attorneys at the Federal Election Commission who developed regulations to implement sweeping campaign finance reform legislation. Ms. Dinh is a graduate of the George Washington University Law School and the University of Pennsylvania Wharton School of Business.
Please wait ...